news2023-03-09T13:10:55+01:00

news

TAmiRNA GmbH is part of the EU-funded Innovative Training Network FIDELIO

Diabetes mellitus is a widespread metabolic disease, with negative/adverse effects on many organ systems. Diabetes also significantly affects bone health. An increased risk of bone fractures and impaired fracture healing has been observed in patients, but the mechanisms are not fully understood. In order to investigate the links between diabetes and the bone system, the EU project "FIDELIO" will run for four years [...]

By |September 18th, 2019|Categories: biomarkers, bone diseases, diabetes, microRNAs, Personalized medicine|Tags: , , , , , |Comments Off on TAmiRNA GmbH is part of the EU-funded Innovative Training Network FIDELIO

University Medical Center Groningen (UMCG) , TAmiRNA GmbH & Vivomicx BV announce their collaboration to unmask the molecular signature of sepsis induced multi organ failure.

UMCG, TAmiRNA, and Vivomicx today announced their collaboration to unmask the molecular signature of sepsis induced multi organ failure and shed light on diagnosis and therapeutic options. Sepsis is the body’s response to infection. Sepsis kills and disables millions of patients worldwide. The role of the microvasculature in all organs has been identified as central, yet understudied in the pathophysiology leading to Multi [...]

By |June 26th, 2019|Categories: biomarkers, LMD, microRNAs, safety, Vivomicx|Tags: , , , , , , , , |Comments Off on University Medical Center Groningen (UMCG) , TAmiRNA GmbH & Vivomicx BV announce their collaboration to unmask the molecular signature of sepsis induced multi organ failure.

TAmiRNA and advanceCOR receive Eurostars project “thrombomiR”

TAmiRNA and advanceCOR, a drug developing biotechnology company which focuses on personalized medicine in cardiovascular diseases, receive Eurostars project entitled: ”A novel microRNA-based platelet function biomarker for personalized anti-thrombotic treatment”.  The aim of the Eurostars project is to validate the use of the thrombomiR™ kit for management of anti-thrombotic therapies. The thrombomiR™ kit is a minimally invasive blood test that can determine changes [...]

By |April 30th, 2019|Categories: biomarkers, drug development, drug discovery, microRNAs, Personalized medicine, safety, thrombomiR|Tags: , , , , , , , , |Comments Off on TAmiRNA and advanceCOR receive Eurostars project “thrombomiR”

TAmiRNA is part of the international IMI2 project “Translational Safety Biomarker Pipeline”

Early and reliable detection and monitoring of adverse events is essential for improving of patient safety, reducing late attrition of drug candidates, and enhancing understanding of toxic mechanisms. The Translational Safety Biomarker Pipeline (TransBioLine) project will focus on development of biomarkers of injury for liver, kidney, pancreas, vasculature, central nervous system (CNS) and the development of non-invasive microRNA biomarkers using liquid biopsies. The [...]

By |April 30th, 2019|Categories: biomarkers, drug development, drug discovery, exosomes, liquid biopsies, microRNAs, Personalized medicine, safety|Tags: , , , , , , , , |Comments Off on TAmiRNA is part of the international IMI2 project “Translational Safety Biomarker Pipeline”

Predicting Postoperative Liver Dysfunction Based on Blood Derived MicroRNA Signatures.

We want to draw your attention to the latest publication of the Department of Surgery, Medical University of Vienna, in cooperation with TAmiRNA GmbH, in Hepatology. "Predicting Postoperative Liver Dysfunction Based on Blood Derived MicroRNA Signatures." Hepatology. 2019 Jun;69(6):2636-2651. Personalized medicine in liver surgery. Together with colleagues from Medical University Vienna we could show that plasma levels of three miRNAs can accurately predict liver dysfunction [...]

Ask the Expert: kit or service, NGS or qPCR – what is the best choice for my microRNA biomarker project?

Can't find the answer to your question on our site? Not sure which method is right for your research? Get in touch with our experts at TAmiRNA - they will answer your questions and help to move from your ideas to results. Get in touch

By |January 30th, 2019|Categories: biomarkers, exosomes, liquid biopsies, LMD, microRNA services, microRNAs, osteomiR, thrombomiR|Tags: , , , , , , |Comments Off on Ask the Expert: kit or service, NGS or qPCR – what is the best choice for my microRNA biomarker project?

Eager to learn more about TAmiRNA qPCR kits and the exciting field of microRNAs?

Click here to read our Technotes

By |August 8th, 2018|Categories: biomarker, liquid biopsies, microRNAs, osteomiR, thrombomiR|Tags: , , , , , , , , |Comments Off on Eager to learn more about TAmiRNA qPCR kits and the exciting field of microRNAs?

TAmiRNA receives FFG EARLY STAGE for the development of novel theranostic solutions based on microRNA biomarkers – the PATH project.

PATH stands for "Project for Advancing the Application of MicroRNAs as THeranostic Biomarkers". The aim of this project is to create optimal framework conditions for successful research and development of the application of microRNAs as theranostic biomarkers. “Theranostics” means the increasingly close integration of diagnostics and therapy. The aim of theranostics is to enable the right therapy for the right patient at the [...]

By |July 16th, 2018|Categories: biomarkers, exosomes, liquid biopsies, microRNAs|Tags: , , , , , |Comments Off on TAmiRNA receives FFG EARLY STAGE for the development of novel theranostic solutions based on microRNA biomarkers – the PATH project.

Improving Quality Of Life For Patients With Osteoporosis Using MicroRNAs

We want to draw your attention to our latest article “Improving Quality Of Life For Patients With Osteoporosis Using MicroRNAs” Our simulations provide evidence for the utility of the osteomiR™ test for fracture risk assessment, and, furthermore, highlight the general potential of circulating microRNAs to be exploited as minimal-invasive diagnostic tools. Click here to read the study

By |May 16th, 2018|Categories: aging, biomarker, biomarkers, bone fracture risk assessment, microRNAs, osteomiR|Tags: , , , , , , |Comments Off on Improving Quality Of Life For Patients With Osteoporosis Using MicroRNAs

New evidence for associations between miRNAs and metabolic unhealthy conditions

We want to draw your attention to the latest publication in cooperation with TAmiRNA GmbH, in Obesity Surgery.” Reduction of Premature Aging Markers After Gastric Bypass Surgery in Morbidly Obese Patients.” The findings indicate a significant reduction of the proinflammatory SASP after bariatric surgery. An increase in telomere length and reduced oxidative stress at telomeres was observed. Moreover, miR10a-5p which is downregulated during [...]

By |April 27th, 2018|Categories: aging, biomarker, biomarkers, microRNAs|Tags: , , , , |Comments Off on New evidence for associations between miRNAs and metabolic unhealthy conditions
Go to Top